Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Based on available information, it is concluded that Sodium bis(trifluoromethylsulfonyl)imide does not exhibit any potential for mutagenicity.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Since no in vitro gene mutation study in bacteria is available for Sodium bis(trifluoromethylsulfonyl)imide, the results from the structural analogue Lithium bis(trifluoromethylsulfonyl)imide are used instead (for details see Read-across justification as attached in section 13). The structural analogue Lithium bis(trifluoromethylsulfonyl)imide did not induce an increased mutation frequency in a GLP-compliant bacterial reverse mutation assay, performed according to OECD guideline 471.

Justification for classification or non-classification

Based on the available data and in accordance with EU Classification, Labeling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, classification is not necessary for mutagenicity.

Categories Display